The synthesis of indolo- and pyrrolo[2,1-a]isoquinolines

Tetrahedron Letters

Volumn 45, Issue 6, 2004, Pages 1117-1119

  De Koning, Charles B ^a   Michael, Joseph P ^a   Pathak, Rakhi ^a   Van Otterlo, Willem A L ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Isoquinolines; Potassium t butoxide

Indexed keywords

14 METHYL 8 PHENYLBENZ[H]INDOLO[2,1 A]ISOQUINOLINE; CARBOXYLIC ACID DERIVATIVE; INDOLO[2,1 A]ISOQUINOLINE; ISOQUINOLINE DERIVATIVE; PYRROLE DERIVATIVE; PYRROLO[2,1 A]ISOQUINOLINE DERIVATIVE; TERT BUTYL 2 (2 FORMYL 3,4 DIHYDRO 1 NAPHTHALENYL) 3 METHYL 1H INDOLE 1 CARBOXYLATE; UNCLASSIFIED DRUG;

ARTICLE; CYCLIZATION; DRUG SYNTHESIS; PRECURSOR;

EID: 0742287101     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2003.12.020     Document Type: Article

References (22)

1. Bentley K.W. Nat. Prod. Rep. 20:2003;342-365.
2. Balasubramanian M., Scriven E.F.V. Isoquinoline and its derivatives. Sainsbury M. Second Supplements to the 2nd Edition of Rodd's Chemistry of Carbon Compounds, Vol IV: Heterocyclic Compounds, Parts F and G. 1998;163-216 Elsevier, Amsterdam.
3. Andreae S. Isoquinolines (Benzo[b]pyridines). Kreher R.P. Heteroarenes II, Part 1. Vol. E7a:1991;571-740 Georg Thieme, Stuttgart.
4. Kathawala F.G. Isoquinolines. 1990;New York, Wiley.
5. Scott J.D., Williams R.M. Chem. Rev. 102:2002;1669-1730.
6. For an extensive review see: Bringmann G., Pokorny F. Cordell G.A. The Alkaloids. Chemistry and Pharmacology. Vol. 46:1995;127-271 Academic, New York.
7. de Koning C.B., van Otterlo W.A.L., Michael J.P. Tetrahedron. 59:2003;8337-8345.
8. de Koning C.B., Michael J.P., van Otterlo W.A.L. Synlett. 2002;2065-2067.
9. de Koning C.B., Michael J.P., van Otterlo W.A.L. J. Chem. Soc., Perkin Trans. 1. 2000;799-811.
10. For an approach to a 1,2-dihydroisoquinoline ring system using ruthenium-mediated isomerization and ring-closing metathesis see: van Otterlo W.A.L., Pathak R., de Koning C.B. Synlett. 2003;1859-1861.
11. Orito K., Harada R., Uchiito S., Tokuda M. Org. Lett. 2:2000;1799-1801.
12. Meyers A.I., Sielecki T.M. J. Am. Chem. Soc. 113:1991;2789-2790.
13. Ambros R., Schneider M.R., von Angerer S. J. Med. Chem. 33:1990;153-160.
14. For example, see: de Koning C.B., Michael J.P., Nhlapo J.M., Pathak R., van Otterlo W.A.L. Synlett. 2003;705-707.
15. From the ongoing Ph.D of R. Pathak, University of the Witwatersrand.
16. +, 47%), 287 (83), 273 (30), 272 (100), 270 (32), 269 (32), 258 (50), 130 (29) and 57 (62).
17. de Koning C.B., Michael J.P., Rousseau A.L. J. Chem. Soc., Perkin Trans. 1. 2000;787-797.
18. de Koning C.B., Michael J.P., Rousseau A.L. J. Chem. Soc., Perkin Trans. 1. 2000;1705-1713.
19. +, 100), 356 (54), 354 (21), 278 (11) and 171 (11).
20. Zhang P., Liu R., Cook J.M. Tetrahedron Lett. 36:1995;3103-3106.
21. Choi D.-S., Huang S., Huang M., Barnard T.S., Adams R.D., Seminario J.M., Tour J.M. J. Org. Chem. 63:1998;2646-2655.
22. Gilow H.M., Burton D.E. J. Org. Chem. 46:1981;2221-2225.